Microbial models of drug metabolism: Microbial transformations of Trimegestone (R) (RU27987), a 3-keto-Delta(4,9(10))-19-norsteroid drug

Citation
I. Lacroix et al., Microbial models of drug metabolism: Microbial transformations of Trimegestone (R) (RU27987), a 3-keto-Delta(4,9(10))-19-norsteroid drug, BIO MED CH, 7(11), 1999, pp. 2329-2341
Citations number
34
Categorie Soggetti
Chemistry & Analysis
Journal title
BIOORGANIC & MEDICINAL CHEMISTRY
ISSN journal
09680896 → ACNP
Volume
7
Issue
11
Year of publication
1999
Pages
2329 - 2341
Database
ISI
SICI code
0968-0896(199911)7:11<2329:MMODMM>2.0.ZU;2-N
Abstract
Screening microorganisms for the biotransformation of the 3-keto-Delta(4.9( 10))-19-norsteroid RU27987 (Trimegestone(R)) resulted in the isolation of n ine identified metabolites, some of them being selectively produced by diff erent strains. Eight metabolites were found to be hydroxylated on various p ositions of the rings, and one was additionally epoxidized. These microbial metabolites could be used as chromatographic standards and two of them wer e found identical to the unknown major human metabolites, Moreover, most mi crobial metabolites were produced in sufficient amounts to be tested for th eir biological activities. All these features demonstrate the usefulness an d versatility of microbial biotransformation systems as a tool for early id entification and convenient production of potentially active mammalian and non-mammalian metabolites. (C) 1999 Elsevier Science Ltd. All rights reserv ed.